{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:27:29Z","timestamp":1789032449243,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jns.2021.117423","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T12:02:21Z","timestamp":1616846541000},"page":"117423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["CNS involvement in systemic vasculitides"],"prefix":"10.1016","volume":"424","author":[{"given":"Neil","family":"Scolding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2021.117423_bb0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/practneurol-2018-002002","article-title":"The diagnosis of primary central nervous system vasculitis","volume":"20","author":"Rice","year":"2020","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0010","doi-asserted-by":"crossref","first-page":"iii55","DOI":"10.1093\/rheumatology\/keaa075","article-title":"Vasculitis and the peripheral nervous system","volume":"59","author":"Ginsberg","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jns.2021.117423_bb0015","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.27240","article-title":"Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database","volume":"62","author":"Pagnoux","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117423_bb0020","first-page":"553","article-title":"Central nervous system polyarteritis nodosa","volume":"153","author":"Rosenberg","year":"1990","journal-title":"West. J. Med."},{"key":"10.1016\/j.jns.2021.117423_bb0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.54.4.883","article-title":"Early lacunar strokes complicating polyarteritis nodosa: thrombotic microangiopathy","volume":"54","author":"Reichart","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.117423_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.410330103","article-title":"Neurological involvement in Wegener\u2019s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic","volume":"33","author":"Nishino","year":"1993","journal-title":"Ann.Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archneur.58.8.1215","article-title":"Standardized neurologic evaluations of 128 patients with Wegener granulomatosis","volume":"58","author":"de Groot","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10067-017-3835-y","article-title":"Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study","volume":"37","author":"Fragoulis","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jns.2021.117423_bb0045","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1210\/jc.2014-1962","article-title":"Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic experience","volume":"99","author":"Kapoor","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jns.2021.117423_bb0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(97)80118-3","article-title":"Primary systemic vasculitis","volume":"394","author":"Savage","year":"1997","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jns.2021.117423_bb0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty- five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117423_bb0060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(03)12518-4","article-title":"Churg-Strauss syndrome","volume":"361","author":"Noth","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jns.2021.117423_bb0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis study group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117423_bb0070","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.autrev.2017.07.007","article-title":"Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): report of 26 patients and review of the literature","volume":"16","author":"Andre","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jns.2021.117423_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4065\/70.4.337","article-title":"Neurologic manifestations of Churg-Strauss syndrome","volume":"70","author":"Sehgal","year":"1995","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jns.2021.117423_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11908-016-0538-5","article-title":"The clinical diagnosis and Management of Kawasaki Disease: a review and update","volume":"18","author":"Zhu","year":"2016","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.jns.2021.117423_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00296-020-04749-4","article-title":"Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management","volume":"41","author":"Kabeerdoss","year":"2021","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jns.2021.117423_bb0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0387-7604(83)80041-2","article-title":"Neurological complications in Kawasaki disease","volume":"5","author":"Terasawa","year":"1983","journal-title":"Brain Dev."},{"key":"10.1016\/j.jns.2021.117423_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.40591","article-title":"Review: nervous system disease in systemic lupus erythematosus: current status and future directions","volume":"71","author":"Hanly","year":"2019","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117423_bb0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jnnp.2009.200071","article-title":"Neurolupus","volume":"10","author":"Joseph","year":"2010","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-196807000-00002","article-title":"The neurological manifestations of systemic lupus erythematosus","volume":"47","author":"Johnson","year":"1968","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jns.2021.117423_bb0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0049-0172(79)80009-8","article-title":"Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955\u20131977","volume":"8","author":"Ellis","year":"1979","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117423_bb0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410230411","article-title":"Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura","volume":"23","author":"Devinsky","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0120","first-page":"732","article-title":"Brain pathology in systemic lupus erythematosus","volume":"19","author":"Hanly","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jns.2021.117423_bb0125","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00415-016-8336-4","article-title":"Neurosarcoidosis: a clinical approach to diagnosis and management","volume":"264","author":"Ibitoye","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/sarh.2000.8364","article-title":"Sarcoidosis and systemic vasculitis","volume":"30","author":"Fernandes","year":"2000","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117423_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archneur.1975.00490460087014","article-title":"Cerebral vasculitis in rheumatoid arthritis","volume":"32","author":"Ramos","year":"1975","journal-title":"Arch.Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0140","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.117423_bb0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00002281-199601000-00004","article-title":"Vasculitis associated with infectious agents","volume":"8","author":"Lie","year":"1996","journal-title":"Curr.Opin.Rheumatol."},{"key":"10.1016\/j.jns.2021.117423_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/BOR.0000000000000348","article-title":"Infections and vasculitis","volume":"29","author":"Thomas","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2021.117423_bb0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ana.410140509","article-title":"Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches","volume":"14","author":"Hilt","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0160","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","article-title":"Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment","volume":"8","author":"Gilden","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0165","first-page":"47","article-title":"Vasculitis simulators and vasculitis look-alikes","volume":"4","author":"Lie","year":"1992","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2021.117423_bb0170","first-page":"1769","article-title":"Intravascular malignant lymphoma (\u201cmalignant angioendotheliomatosis\u201d) mimicking primary angiitis of the central nervous system","volume":"22","author":"Sienknecht","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jns.2021.117423_bb0175","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/art.1780350719","article-title":"Malignant angioendotheliomatosis (intravascular lymphomatosis) clinically simulating primary angiitis of the central nervous system [see comments]","volume":"35","author":"Lie","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117423_bb0180","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s00415-015-7720-9","article-title":"Idiopathic hypereosinophilic syndrome: a new cause of vasculitis of the central nervous system","volume":"262","author":"Rice","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.117423_bb0185","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJM197011052831901","article-title":"Necrotizing angiitis associated with drug abuse","volume":"283","author":"Citron","year":"1970","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117423_bb0190","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1212\/WNL.46.6.1741","article-title":"Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases","volume":"46","author":"Aggarwal","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.117423_bb0195","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.40.7.1092","article-title":"Biopsy-proven cerebral vasculitis associated with cocaine abuse","volume":"40","author":"Krendel","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.117423_bb0200","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/01.STR.22.11.1437","article-title":"Cerebral vasculitis associated with cocaine abuse","volume":"22","author":"Fredericks","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2021.117423_bb0205","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1520\/JFS13463J","article-title":"Cerebral vasculitis associated with cocaine abuse","volume":"38","author":"Morrow","year":"1993","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jns.2021.117423_bb0210","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","article-title":"BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jns.2021.117423_bb0215","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.jns.2021.117423_bb0220","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann.Intern.Med."},{"key":"10.1016\/j.jns.2021.117423_bb0225","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2021.117423_bb0230","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117423_bb0235","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","volume":"304","author":"Hiemstra Tf","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2021.117423_bb0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated Vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117423_bb0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal Vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117423_bb0250","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2021.117423_bb3000","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117422","article-title":"Primary central nervous system vasculitis \u2013 An update on diagnosis, differential diagnosis and treatment","author":"Kraemer","year":"2021","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:57:56Z","timestamp":1758383876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":51,"alternative-id":["S0022510X21001167"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117423","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNS involvement in systemic vasculitides","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117423"}}